279 related articles for article (PubMed ID: 19270647)
1. Epithelial-to-mesenchymal transition in the development and progression of adenocarcinoma and squamous cell carcinoma of the lung.
Prudkin L; Liu DD; Ozburn NC; Sun M; Behrens C; Tang X; Brown KC; Bekele BN; Moran C; Wistuba II
Mod Pathol; 2009 May; 22(5):668-78. PubMed ID: 19270647
[TBL] [Abstract][Full Text] [Related]
2. Epithelial-Mesenchymal Transition in Non Small-cell Lung Cancer.
Tsoukalas N; Aravantinou-Fatorou E; Tolia M; Giaginis C; Galanopoulos M; Kiakou M; Kostakis ID; Dana E; Vamvakaris I; Korogiannos A; Tsiambas E; Salemis N; Kyrgias G; Karameris A; Theocharis S
Anticancer Res; 2017 Apr; 37(4):1773-1778. PubMed ID: 28373440
[TBL] [Abstract][Full Text] [Related]
3. The relationship between Bmi-1 and the epithelial-mesenchymal transition in lung squamous cell carcinoma.
Huang J; Qiu Y; Chen G; Huang L; He J
Med Oncol; 2012 Sep; 29(3):1606-13. PubMed ID: 21656027
[TBL] [Abstract][Full Text] [Related]
4. The role of the integrin alpha v beta6 in regulating the epithelial to mesenchymal transition in oral cancer.
Ramos DM; Dang D; Sadler S
Anticancer Res; 2009 Jan; 29(1):125-30. PubMed ID: 19331141
[TBL] [Abstract][Full Text] [Related]
5. Incomplete epithelial-mesenchymal transition in p16-positive squamous cell carcinoma cells correlates with β-catenin expression.
Umbreit C; Flanjak J; Weiss C; Erben P; Aderhold C; Faber A; Stern-Straeter J; Hoermann K; Schultz JD
Anticancer Res; 2014 Dec; 34(12):7061-9. PubMed ID: 25503133
[TBL] [Abstract][Full Text] [Related]
6. Incomplete expression of epithelial-mesenchymal transition markers in idiopathic pulmonary fibrosis.
Morbini P; Inghilleri S; Campo I; Oggionni T; Zorzetto M; Luisetti M
Pathol Res Pract; 2011 Sep; 207(9):559-67. PubMed ID: 21798671
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of epithelial-mesenchymal transition-related markers between cancer tissue and tumor emboli].
He N; Wu GF; Zhao HY; Han HX
Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):758-61. PubMed ID: 22336160
[TBL] [Abstract][Full Text] [Related]
8. Correlation of epithelial-mesenchymal transition markers with clinicopathologic parameters in adenocarcinomas and squamous cell carcinoma of the lung.
Kim SH; Kim JM; Shin MH; Kim CW; Huang SM; Kang DW; Suh KS; Yi ES; Kim KH
Histol Histopathol; 2012 May; 27(5):581-91. PubMed ID: 22419022
[TBL] [Abstract][Full Text] [Related]
9. The immunohistochemical investigations of cadherin "switch" during epithelial-mesenchymal transition of tongue squamous cell carcinoma.
Afrem MC; Mărgăritescu C; Crăiţoiu MM; Ciucă M; Şarlă CG; Cotoi OS
Rom J Morphol Embryol; 2014; 55(3 Suppl):1049-56. PubMed ID: 25607384
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Akt activity induces the mesenchymal-to-epithelial reverting transition with restoring E-cadherin expression in KB and KOSCC-25B oral squamous cell carcinoma cells.
Hong KO; Kim JH; Hong JS; Yoon HJ; Lee JI; Hong SP; Hong SD
J Exp Clin Cancer Res; 2009 Feb; 28(1):28. PubMed ID: 19243631
[TBL] [Abstract][Full Text] [Related]
11. Expression of E-cadherin and vimentin in oral squamous cell carcinoma.
Zhou J; Tao D; Xu Q; Gao Z; Tang D
Int J Clin Exp Pathol; 2015; 8(3):3150-4. PubMed ID: 26045832
[TBL] [Abstract][Full Text] [Related]
12. Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases.
Toll A; Masferrer E; Hernández-Ruiz ME; Ferrandiz-Pulido C; Yébenes M; Jaka A; Tuneu A; Jucglà A; Gimeno J; Baró T; Casado B; Gandarillas A; Costa I; Mojal S; Peña R; de Herreros AG; García-Patos V; Pujol RM; Hernández-Muñoz I
J Dermatol Sci; 2013 Nov; 72(2):93-102. PubMed ID: 23928229
[TBL] [Abstract][Full Text] [Related]
13. Expression of PRMT5 in lung adenocarcinoma and its significance in epithelial-mesenchymal transition.
Ibrahim R; Matsubara D; Osman W; Morikawa T; Goto A; Morita S; Ishikawa S; Aburatani H; Takai D; Nakajima J; Fukayama M; Niki T; Murakami Y
Hum Pathol; 2014 Jul; 45(7):1397-405. PubMed ID: 24775604
[TBL] [Abstract][Full Text] [Related]
14. Epithelial-Mesenchymal Transition Predicts Survival in Oral Squamous Cell Carcinoma.
Wangmo C; Charoen N; Jantharapattana K; Dechaphunkul A; Thongsuksai P
Pathol Oncol Res; 2020 Jul; 26(3):1511-1518. PubMed ID: 31471883
[TBL] [Abstract][Full Text] [Related]
15. Snail-associated epithelial-mesenchymal transition promotes oesophageal squamous cell carcinoma motility and progression.
Usami Y; Satake S; Nakayama F; Matsumoto M; Ohnuma K; Komori T; Semba S; Ito A; Yokozaki H
J Pathol; 2008 Jul; 215(3):330-9. PubMed ID: 18491351
[TBL] [Abstract][Full Text] [Related]
16. HR+HER2- breast cancers with growth factor receptor-mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells.
Desai K; Aiyappa R; Prabhu JS; Nair MG; Lawrence PV; Korlimarla A; Ce A; Alexander A; Kaluve RS; Manjunath S; Correa M; Srinath BS; Patil S; Kalamdani A; Prasad M; Sridhar TS
Tumour Biol; 2017 Mar; 39(3):1010428317695028. PubMed ID: 28349782
[TBL] [Abstract][Full Text] [Related]
17. Epithelial-mesenchymal Transition (EMT) is Correlated with Patient's Prognosis of Lung Squamous Cell Carcinoma.
Aruga N; Kijima H; Masuda R; Onozawa H; Yoshizawa T; Tanaka M; Inokuchi S; Iwazaki M
Tokai J Exp Clin Med; 2018 Apr; 43(1):5-13. PubMed ID: 29637533
[TBL] [Abstract][Full Text] [Related]
18. Altered expression of adhesion molecules and epithelial-mesenchymal transition in silica-induced rat lung carcinogenesis.
Blanco D; Vicent S; Elizegi E; Pino I; Fraga MF; Esteller M; Saffiotti U; Lecanda F; Montuenga LM
Lab Invest; 2004 Aug; 84(8):999-1012. PubMed ID: 15195114
[TBL] [Abstract][Full Text] [Related]
19. Inversed Expression Patterns of S100A4 and E-Cadherin in Cervical Cancers: Implication in Epithelial-Mesenchymal Transition.
Liu M; Liu J; Yang B; Gao X; Gao LL; Kong QY; Zhang P; Li H
Anat Rec (Hoboken); 2017 Dec; 300(12):2184-2191. PubMed ID: 28921916
[TBL] [Abstract][Full Text] [Related]
20. Epithelial to mesenchymal transition in head and neck squamous carcinoma: association of Src activation with E-cadherin down-regulation, vimentin expression, and aggressive tumor features.
Mandal M; Myers JN; Lippman SM; Johnson FM; Williams MD; Rayala S; Ohshiro K; Rosenthal DI; Weber RS; Gallick GE; El-Naggar AK
Cancer; 2008 May; 112(9):2088-100. PubMed ID: 18327819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
